Filing Details

Accession Number:
0001140361-17-010314
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-02 17:16:42
Reporting Period:
2017-02-28
Filing Date:
2017-03-02
Accepted Time:
2017-03-02 17:16:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
881524 Vivus Inc VVUS Pharmaceutical Preparations (2834) 943136179
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557543 North Tide Capital, Llc 500 Boylston Street
Suite 1860
Boston MA 02116
No No Yes No
1594068 Conan Laughlin 500 Boylston Street
Suite 1860
Boston MA 02116
Yes No Yes No
1594882 North Tide Capital Master, Lp 500 Boylston Street
Suite 1860
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-02-28 25,500 $1.12 11,943,500 No 4 S Indirect See Footnote
Common Stock Disposition 2017-03-01 72,600 $1.14 11,870,900 No 4 S Indirect See Footnote
Common Stock Disposition 2017-03-01 42,000 $1.13 11,828,900 No 4 S Indirect See Footnote
Common Stock Disposition 2017-03-02 20,000 $1.13 11,808,900 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. North Tide Capital, LLC ("North Tide") serves as investment manager for North Tide Capital Master, LP (the "Master Fund") and a managed account (the "Account"). Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
  2. Of the shares sold on February 28, 2017, 23,580 shares were held for the account of the Master Fund, 1,920 shares were held for the account of the Account, and all of such shares may be deemed to have been beneficially owned by North Tide and Mr. Laughlin.
  3. Of the shares sold on March 1, 2017 at a price of $1.1365, 67,134 shares were held for the account of the Master Fund, 5,466 shares were held for the account of the Account, and all of such shares may be deemed to have been beneficially owned by North Tide and Mr. Laughlin.
  4. Of the shares sold on March 1, 2017 at a price of $1.1318, 38,838 shares were held for the account of the Master Fund, 3,162 shares were held for the account of the Account, and all of such shares may be deemed to have been beneficially owned by North Tide and Mr. Laughlin.
  5. Of the shares sold on March 2, 2017, 18,494 shares were held for the account of the Master Fund, 1,506 shares were held for the account of the Account, and all of such shares may be deemed to have been beneficially owned by North Tide and Mr. Laughlin. As of March 2, 2017, 10,296,299 shares were held for the account of the Master Fund, 1,512,601 shares were held for the account of the Account, and all of such shares may be deemed beneficially owned by North Tide and Mr. Laughlin.